Latest news
Cohance Lifesciences' 'Weakest Quarter' Prompts Target Price Cut By ICICI Securities - NDTV ProfitNDTV Profit · Thu, 06 Aug 2026 06:38:07 GMTCohance Lifesciences Q1 Review: Brokerages Split After Earnings Slump — Check Potential Upside, Target Price - NDTV ProfitNDTV Profit · Thu, 06 Aug 2026 02:08:49 GMTOncology Experts Review Key ASCO 2026 Data for Daraxonrasib and Other Novel Therapies in GI Cancers - OncLiveOncLive · Wed, 29 Jul 2026 07:00:00 GMTBiotech & Pharma Q2 2025: AI Innovations, M&A Moves, and Policy Challenges Unveiled - Investing News NetworkInvesting News Network · Mon, 27 Jul 2026 21:15:00 GMT